TPE Filtration Sets
Therapeutic Plasma Exchange associated with positive clinical outcomes1
Therapeutic Plasma Exchange (TPE) is an extracorporeal blood purification technique used to treat patients with a variety of disorders and has become a relatively common treatment modality. It is associated with positive clinical outcomes in the treatment of Guillain-Barré Syndrome, Thrombotic Thrombocytopenic Purpura (TTP), Myasthenia Gravis and Goodpasture syndrome.
Expand beyond CRRT to deliver membrane Therapeutic Plasma Exchange in your ICU
Treatment indications for Therapeutic Plasma Exchange have increased over time. What if you could deliver membrane Therapeutic Plasma Exchange on the same device you use for CRRT? With PrisMax and Prismaflex, you gain flexibility to deliver multiple therapies at the bedside anytime with ease and confidence in a simple and efficient manner.
Gain control and flexibility with PrisMax and Prismaflex to deliver multiple therapies at the bedside
Simplicity
Designed for improved ease-of-use for Therapeutic Plasma Exchange delivery so you can focus more on patient care
Confidence
Powered by Prismaflex and PrisMax, the system provides enhanced safety features for greater confidence in the delivery of TPE therapy
Efficiency
Provides autonomy and helps to streamline operations in your ICU when delivering the therapy on the PrisMax and Prismaflex systems
Filtration TPE Sets powered by PrisMax and Prismaflex expand treatment options in your ICU
Simplicity and improved ease-of-use for Therapeutic Plasma Exchange delivery
- Setting up and executing a Therapeutic Plasma Exchange procedure on the Prismaflex and PrisMax systems is similar to setting up a CRRT procedure,2 which may reduce the amount of additional training required.
- The intuitive user interface of PrisMax and Prismaflex may help to support smooth therapy initiation.2,3
- The system offers the capability for citrate anticoagulation and integrated syringe pump for heparin anticoagulation.1
Enhanced safety features for greater confidence
- The PrisMax and Prismaflex systems offers the ability to delay the start of therapy until the TPE circuit has been filled with blood before initiating treatment.2
- The self-regulating pressure system can automatically accommodate blood flow rate adjustments.2
- Flow rate capabilities allow adjustments for lower body weight patients.2
Efficiencies to help streamline operations in your ICU
- Hospitals that already own a PrisMax or Prismaflex device can run Therapeutic Plasma Exchange without purchasing a new device.2
- The only additional incremental cost includes the purchase of TPE sets, anticoagulant, tube sets, replacement solution, and procedural disposables,2 allowing an affordable and predictable treatment cost.4
TPE with the PrisMax system allows you to autonomously support time critical indications with Therapeutic Plasma Exchange therapy, 24/7. This can help meet diverse patient needs and the demands of multiple critical care therapies
in your ICU.
Baxter offers different TPE filtration sets for plasma protein removal to meet your patients’ needs
Related Products
IMPORTANT SAFETY INFORMATION
The Prismaflex TPE1000/TPE2000 set is indicated for use only with the Prismaflex control unit or with the PrisMax control unit (in countries where PrisMax is cleared or registered), after having selected TPE therapy (therapeutic plasma exchange). The Prismaflex TPE1000/TPE2000 set is intended for use in therapeutic plasma exchange, thus in diseases where removal of plasma components in indicated.
The PrisMax control unit is intended for:
• Continuous Renal Replacement Therapy (CRRT) for patients with acute renal failure and/or fluid overload.
• Therapeutic Plasma Exchange (TPE) therapy for patients with diseases where removal of plasma components is indicated.
• Hemoperfusion (HP) for patients with conditions where immediate removal of substances by adsorption is indicated.
• Extracorporeal CO2 Removal (ECCO2R) for patients with conditions where extracorporeal elimination of carbon dioxide is indicated.
The Prismaflex control unit is intended for:
• Continuous Renal Replacement Therapy for patients with acute renal failure and/or fluid overload.
• Therapeutic Plasma Exchange Therapy for patients with diseases where removal of plasma components is indicated.
• Hemoperfusion for patients with conditions where immediate removal of substances by adsorption is indicated.
• Hemopurification for patients with conditions where extracorporeal elimination of carbon dioxide is indicated.
For safe and proper use of the products mentioned herein, please refer to the Operator’s Manual or Instructions for Use.
